Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rosetta Genomics Ltd ROSGQ

Healthcare Biotechnology Diagnostics & Research
Rosetta Genomics Ltd. is an Israel-based company engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA), and protein biomarkers, and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence... see more

Recent & Breaking News (GREY:ROSGQ)

Rosetta Genomics' Cancer Origin Test Highlighted on The Dr. Steve Show

Marketwired September 23, 2013

Rosetta Genomics Granted U.S. Patent Allowance

Marketwired September 12, 2013

Rosetta Genomics Reports Financial Results for the First Six Months of 2013

Marketwired September 10, 2013

Rosetta Genomics Executes Credentialing Agreements With Two National Healthcare Preferred Provider Networks

Marketwired September 9, 2013

Rosetta Genomics to Host Business Update Conference Call on September 10, 2013

Marketwired September 4, 2013

Rosetta Genomics and Ramot at Tel Aviv University Awarded Grant From Israeli Office of the Chief Scientist to Support Development of microRNA Oncology Therapeutics

eTeligis August 8, 2013

Rosetta Genomics and Ramot at Tel Aviv University Awarded Grant From Israeli Office of the Chief Scientist to Support Development of microRNA Oncology Therapeutics

Marketwired August 8, 2013

Rosetta Genomics Announces Launch of New Website

Marketwired August 5, 2013

Rosetta Genomics Receives Notice of Allowance for Key U.S. Patent for the Rosetta Lung Cancer Test

Accesswire July 25, 2013

Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Test(TM)

PR Newswire June 13, 2013

Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider Network

PR Newswire June 7, 2013

Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript

PR Newswire June 6, 2013

Rosetta Genomics to Increase the Number of U.S. Sales Territories

PR Newswire June 4, 2013

Rosetta Genomics Announces Presence at ASCO 2013

PR Newswire May 28, 2013

Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

PR Newswire May 22, 2013

Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2

PR Newswire May 20, 2013

Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories

PR Newswire May 10, 2013

Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting

PR Newswire May 7, 2013

Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories

PR Newswire April 18, 2013

Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013

PR Newswire April 2, 2013